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Clinicopathological characteristics of interstitial foam cells in and Alport syndrome [1]. They have been demonstrated
membranous nephropathy. to be positive for markers of monocyte/macrophage
Background. Interstitial foam cells are occasionally ob- (Mφ), and their appearance has been reported to beserved in various renal diseases, and they have been reported
associated with prolonged proteinuria or hyperlipidemiato belong to the monocyte/macrophage (Mφ) lineage and to
[1, 2]. However, we recently reported a patient with IgAbe associated with heavy proteinuria and hyperlipidemia. We
investigated the characteristics of interstitial foam cells and nephropathy who did not have hyperlipidemia and heavy
their association with proteinuria and hyperlipidemia in idio- proteinuria [3]. In this study, we investigated the charac-
pathic membranous nephropathy (MN). teristics of interstitial foam cells in idiopathic membra-Methods. Patients with MN (N 5 320) were divided into
nous nephropathy (MN) based on clinical and morpho-two groups: group I consisted of 51 patients with interstitial
foam cells, and group II consisted of the other 269 without logical aspects.
foam cells. We compared clinical parameters and the findings
of an immunohistochemical study using monoclonal antibodies
to various types of leukocytes and adhesion molecules. METHODS
Results. The age at renal biopsy, the degree of proteinuria,
We selected 320 patients with MN who were diagnosedserum levels of lipids, and other clinical parameters except for
between 1990 and 1997 by renal biopsy containing moresex ratio were not different between the two groups. The ratio
of nephrotic patients was compatible between groups I (56.9%) than 10 glomeruli. The patients were divided into two
and II (52.8%). All interstitial foam cells were positive for groups: group I included 51 patients (15.9% of total)
CD68 and 25F9, which are markers for Mφ and mature Mφ, with interstitial foam cells, and group II included therespectively, but were negative for CD3 or cytokeratin. Intersti-
other 269 (84.1% of total) without foam cells (Table 1).tial infiltrating cells were positive for CD68 and CD3 but were
Renal biopsy specimens selected from groups I (N 5negative for 25F9. Furthermore, most of interstitial foam cells
were positive for both leukocyte function associated antigen-1 10) and II (N 5 10) were examined by immunohisto-
(LFA-1) and intercellular adhesion molecule-1 (ICAM-1), but chemistry using monoclonal antibodies (mAbs) as pre-
not for ICAM-3 (the third ligand for LFA-1). By contrast,
viously reported [4]. We used anti-CD68 and 25F9 mAbsmost of infiltrating nonfoamy Mφs were positive for ICAM-3
[5] to identify monocytes/macrophages (Mφ) and matureand LFA-1, however, ICAM-1 was observed on only some of
them. Mφ, respectively. We also used anti-CD3 mAb for T
Conclusion. These results suggest that interstitial foam cells cells, anti-CD22 mAb for B cells, and anti-cytokeratin
in MN may not depend on proteinuria nor hyperlipidemia mAb for an epithelial cell marker. MAbs to ICAM-1directly. The accumulation of foam cells, which have character-
(CD54), ICAM-3 (CD50) [6], and LFA-1 (CD11a) wereistics of mature Mφ, may be related to ICAM-1 as a ligand
used to investigate the cell–cell interaction. These mAbsof LFA-1, whereas infiltration of nonfoamy Mφs has a close
relationship with ICAM-3. Thus, the formation of interstitial and other mAbs used in this study are listed in Table 2.
foam cells may be related to the phenotypical transformation
of Mφs.
RESULTS
Clinical parametersInterstitial foam cells are occasionally observed in var-
ious renal diseases, particularly in nephrotic syndrome The age at renal biopsy, the duration from onset, the
degree of proteinuria, serum levels of lipids, and other
clinical parameters except for sex ratio were not differentKey words: macrophages, adhesion molecule, nephrotic syndrome,
Alport syndrome. between the two groups (Table 1). The ratio of nephrotic
patients (urinary protein excretion ^ 3.5 g/day) was com- 1999 by the International Society of Nephrology
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Table 2. Surface antigen expression of foam cells and non-Table 1. Clinical features at the time of biopsy
foamy macrophages positive for CD68 in the interstitium
Group I Group II
foam cell (1) foam cell (2) Non-foamy
Antibody Foam cell macrophage(N 5 51) (N 5 269)
Age years 56.5612.4 55.2 614.0 Dako LCA (CD45, TLC) 111 111
Dako T3 (CD3, mature T cell) 2 2Male:Femalea 25:26 178:91
Nephrotic syndrome 29 (56.9%) 142 (52.8%) Dako CD22 (CD22, B cell) 2 2
Boehringer 25F9 (mature Mφ) 111 6Duration months 31.7664.2 22.0 643.9
Urinary protein g/day 4.763.5 4.4 64.1 Dako LFA-1 (CD11a) 111 111
Dako C3bi receptor (CD11b) 111 111BUN mg/dl 18.468.4 16.5 67.7
Cr mg/dl 1.0260.60 0.90 60.40 Dako p150,95 (CD11c) 111 111
Dako CD18 (CD18) 111 111TP g/dl 5.361.1 5.5 61.1
Albumin g/dl 2.860.9 3.0 60.9 Dako ICAM-1 (CD54) 111 1
Dako ICAM-3 (CD50) 2 111TC mg/dl 293.7683.4 295.4 6103.0
TG mg/dl 206.4699.0 196.9 6122.1 Dako HLA-DR 111 111
Immunotech KL1 (cytokeratin) 2 2SBP mm Hg 137.0620.2 131.9 619.2
DBP mm Hg 80.969.9 77.9 611.8 Values are: 111, .91% positive cells/ total CD68 positive cells; 11, 51–90%
positive cells/total CD68 positive cells; 1, 11–50% positive cells/total CD68All values are mean 6 sd. Statistical analyses were done by Student’s t-test
positive cells; 6, , 10% positive cells/total CD68 positive cells; 2, no positiveexcept for the ratio of sex and the percentage of patients with nephrotic syndrome
cells/total CD68 positive cells. Abbreviations are: LCA, leukocyte common anti-(chi-square test). Abbreviations are: BUN, blood urea nitrogen; Cr, creatinine;
gen; TLC, total leukocyte.TP, total protein; TC, total cholesterol; TG, triglyceride; SBP, systolic blood
pressure; SBP, diastolic blood pressure.
a P , 0.01
cells, whereas T cells were combined with infiltrating
Mφs; and (d) ICAM-1 and ICAM-3 were positive forpatible between groups I and II (56.9 and 52.8%, respec-
foam cells and nonfoamy infiltrating cells, respectively.tively). The ratio of hypercholesterolemic patients (se-
Accordingly, it is unlikely that foam cells are merelyrum total cholesterol $ 250 mg/dl) was 64.0% in the
formed by Mφs, which appear during inflammatory pro-group I and 60.4% in the group II, and this difference
cess and take in lipids. This is supported by clinical analy-was also not significant (by x2; data not shown in Table 1).
sis in this study. The formation of foam cells may be
accompanied by localized phenotypic transformation ofHistological findings
Mφs in the interstitium. We consider that the maturationInfiltrating nonfoamy Mφs were combined with T cells
of Mφs is important in this process.(Table 2). However, T cells seldom appeared around the
The LFA-1/ICAM-1 interaction has been suggested to
foam cells. The distribution of foam cells were entirely
play a critical role for leukocytic accumulation and glomer-
different from that of infiltrating Mφs.
ular damage in glomerulonephritis [7] and for the growth
All interstitial foam cells were positive for CD68 and
of atherosclerotic plaque in atherosclerosis [8]. Intersti-
25F9, but were negative for CD3, CD22, and cytokeratin. tial foam cells may accumulate and expand via the LFA-1/
Meanwhile, interstitial infiltrating cells were positive for ICAM-1 pathway because they were positive for both
CD68 and CD3 but were seldom positive for 25F9. Fur- LFA-1 and ICAM-1 and they were adjoined to each
thermore, interstitial foam cells were positive for both other. By contrast, our results suggest that nonfoamy
LFA-1 and ICAM-1, and they adjoined each other. They Mφ infiltration may be related with ICAM-3. In the pro-
were negative for ICAM-3. By contrast, nonfoamy Mφs cess, the delayed hypersensitivity may be involved be-
were positive for ICAM-3 and LFA-1, but were seldom cause nonfoamy Mφs were combined with T cells [9, 10].
positive for ICAM-1. In conclusion, interstitial foam cells may appear irre-
spective of proteinuria or systemic hyperlipidemia in
MN, and they may be related to the phenotypic transfor-DISCUSSION
mation of Mφs. However, it is uncertain whether theThe duration of proteinuria, the degree of proteinuria,
transformation is associated with abnormalities of local-and the serum lipid levels were not different between
ized lipid metabolism or with Mφ itself.the two groups. These results suggest that interstitial
foam cells may not directly depend on proteinuria nor Reprint requests to Isao Kurihara, M.D., The Second Department
of Internal Medicine, Tohoku University School of Medicine, Sendai,systemic hyperlipidemia.
980-8574, Japan.Interstitial foam cells and infiltrating nonfoamy Mφs
were thought to have different characteristics, although
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